Legend Biotech (LEGN) Soars 42% on Promising Cancer Therapy Results
Legend Biotech snapped a four-day losing streak on Tuesday, jumping 42.22 percent to close at $36.28 apiece following the strong first phase results of its cancer treatment candidate, which saw as much...








